Published in Volume
120, Issue 2 (February 1, 2010)
J Clin Invest. 2010;120(2):645–645.
doi:10.1172/JCI39845C1.
Copyright © 2010, American Society for Clinical
Investigation
Corrigendum
Latent TGF-β–binding protein 4 modifies
muscular dystrophy in mice
Ahlke Heydemann, Ermelinda Ceco, Jackie E. Lim, Michele Hadhazy, Pearl Ryder, Jennifer L. Moran, David R. Beier, Abraham A. Palmer and Elizabeth M. McNally
Published February 1, 2010
Original citation: J. Clin. Invest. 2009;119(12):3703–3712.
doi:10.1172/JCI39845.
Citation for this corrigendum: J. Clin. Invest. 2010;120(2):645.
doi:10.1172/JCI39845C1.
During the preparation of this manuscript, Abraham A. Palmer's affiliation
was given incorrectly. The correct affiliation appears below.
Department of Human Genetics, University of Chicago, Chicago, Illinois, USA.
During the preparation of this manuscript, reference 12 was inadvertently presented
incorrectly. The incorrect reference is on page 3712. The correct reference appears
below.
Department of Human Genetics, University of Chicago, Chicago, Illinois, USA.
12. Cohn, R.D., et al. 2007. Angiotensin II type 1 receptor blockade attenuates
TGF-beta-induced failure of muscle regeneration in multiple myopathic states.
Nat. Med.
13:204–210.
The authors regret the errors.
